Autologous immunotherapies have evolved in recent years to bring breakthrough treatments to the market.
| This week's Fierce LifeSci is brought to you by Catalent Cell & Gene Therapy.
Trouble viewing? Click here. |
| Date: Tuesday, September 15, 2020 Time: 12pm ET / 9am PT Duration: 1 Hour |
|
| In this webinar, Catalent presents a clinical-to-commercial perspective on autologous therapies. Professor Gerhard Bauer will discuss the current challenges associated with autologous therapies and Dr. James Crutchley will speak to the various solutions available for commercial scale-up of advanced therapeutics. Our expert panel will provide insight into: Challenges, advantages and disadvantages of several systems that are currently available for manufacturing of these advanced therapies Manufacturing by Design Methodology developed by Catalent to deliver process efficiencies and scalability How to achieve economies of scale by optimizing across the manufacturing supply chain Register Now |
|
|
| You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.
Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2020 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
